Suppr超能文献

海弗利克极限可能决定初始T细胞的有效克隆多样性。

The Hayflick Limit May Determine the Effective Clonal Diversity of Naive T Cells.

作者信息

Ndifon Wilfred, Dushoff Jonathan

机构信息

African Institute for Mathematical Sciences, Muizenberg 7945, Cape Town, South Africa; African Institute for Mathematical Sciences, Legon, Accra, Ghana; Stellenbosch University, Matieland 7602, Stellenbosch, South Africa; and

Department of Biology, McMaster University, Hamilton, Ontario L8S 4K1, Canada.

出版信息

J Immunol. 2016 Jun 15;196(12):4999-5004. doi: 10.4049/jimmunol.1502343. Epub 2016 May 13.

Abstract

Having a large number of sufficiently abundant T cell clones is important for adequate protection against diseases. However, as shown in this paper and elsewhere, between young adulthood and >70 y of age the effective clonal diversity of naive CD4/CD8 T cells found in human blood declines by a factor of >10. (Effective clonal diversity accounts for both the number and the abundance of T cell clones.) The causes of this observation are incompletely understood. A previous study proposed that it might result from the emergence of certain rare, replication-enhancing mutations in T cells. In this paper, we propose an even simpler explanation: that it results from the loss of T cells that have attained replicative senescence (i.e., the Hayflick limit). Stochastic numerical simulations of naive T cell population dynamics, based on experimental parameters, show that the rate of homeostatic T cell proliferation increases after the age of ∼60 y because naive T cells collectively approach replicative senescence. This leads to a sharp decline of effective clonal diversity after ∼70 y, in agreement with empirical data. A mathematical analysis predicts that, without an increase in the naive T cell proliferation rate, this decline will occur >50 yr later than empirically observed. These results are consistent with a model in which exhaustion of the proliferative capacity of naive T cells causes a sharp decline of their effective clonal diversity and imply that therapeutic potentiation of thymopoiesis might either prevent or reverse this outcome.

摘要

拥有大量足够丰富的T细胞克隆对于充分抵御疾病至关重要。然而,正如本文及其他地方所显示的,在青年期至70岁以上的人群中,人类血液中未成熟CD4/CD8 T细胞的有效克隆多样性下降了10倍以上。(有效克隆多样性既考虑了T细胞克隆的数量,也考虑了其丰度。)这一现象的原因尚未完全明确。此前的一项研究提出,这可能是由于T细胞中某些罕见的、增强复制的突变出现所致。在本文中,我们提出了一个更为简单的解释:这是由于达到复制衰老(即海弗利克极限)的T细胞丢失所致。基于实验参数对未成熟T细胞群体动态进行的随机数值模拟表明,在约60岁之后,稳态T细胞增殖速率增加,因为未成熟T细胞总体上接近复制衰老。这导致在约70岁之后有效克隆多样性急剧下降,与经验数据相符。数学分析预测,如果未成熟T细胞增殖速率不增加,这种下降将比实际观察到的情况晚50多年出现。这些结果与一个模型一致,即未成熟T细胞增殖能力的耗尽导致其有效克隆多样性急剧下降,这意味着胸腺生成的治疗性增强可能预防或逆转这一结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验